The Future of Biologics in Autoimmune Diseases
The Current Landscape of Biologics in Autoimmune Care Biologic drugs have fundamentally reshaped the treatment paradigm for a wide spectrum of autoimmune diseases, including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), and multiple sclerosis. Unlike traditional small-molecule drugs synthesized through chemical processes, biologics are large, complex proteins …